
The high-level roundtable. Steatotic (Fatty) Liver Disease – Strategies for Early Detection and Intervention
On June 13, 2024, Global Fatty Liver Day, ELPA organised a high-level roundtable to discuss Fatty Liver from different perspectives.
The meeting started with a welcome speech and greetings by Marko Korenjak, ELPA President. This was followed by two medical presentations delivered by Prof Dr Romero Gómez, MD, PhD, Professor of Medicine at the University of Seville, Head of Digestive Diseases Department at Virgen del Rocío University Hospitals, Spain and Prof Dr Helena Cortez Pinto, MD, PhD, Professor of Medicine in Faculdade de Medicina, Universidade de Lisboa, Vice-President of the United European Gastroenterology (UEG), Portugal to frame the disease from a medical point of view.
After that, a question-and-answer session allowed the audience to understand the disease’s implications and complexity: its intertwining with other diseases and the struggle to hold policymakers accountable for public health interventions tackling alcohol, commercial determinants of health, and sedentary habits.
In addition, the participation of patient associations from outside Europe gives a broader perspective on the advocacy of good practices and activities.
List of participants:
- Prof Dr Jörn M. Schattenberg, MD, PhD, Member of the Policy, Public Health and Advocacy Committee of the European Association for the Study of the Liver (EASL), Switzerland
- Jeff McIntyre, Vice President, Liver Health Programs, Global Liver Institute, United States
- Alba Gil, Policy Manager, European Public Health Alliance, Belgium
- Vicki Mooney, Executive Director, European Coalition for People living with Obesity (ECPO), Ireland
- Michael Betel, President and CEO of the Fatty Liver Alliance, Canada